OncoMed Pharmaceuticals Inc (OMED) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 524 transactions totaling $38.1M, demonstrating a bullish sentiment with $8.4M in net insider flow. The most recent transaction on Apr 23, 2019 involved a transaction of 80,500 shares valued at $0.
No significant insider buying has been recorded for OMED in the recent period.
No significant insider selling has been recorded for OMED in the recent period.
Based on recent SEC filings, insider sentiment for OMED is bullish with an Insider Alignment Score of 61/100 and a net flow of $8.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at OncoMed Pharmaceuticals Inc (OMED) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading OMED stock, having executed 524 transactions in the past 90 days. The most active insider is Deepika Pakianathan (Executive), who has made 12 transactions totaling $8.0M.
Get notified when executives and directors at OMED file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 23, 2019 | A. Karsen Perry | Executive | Tender | 80,500 | $N/A | $0 | |
| Apr 23, 2019 | Stagg Robert | Executive | Tender | 28,917 | $N/A | $0 | |
| Apr 23, 2019 | Li Yvonne | Executive | Tender | 65,895 | $N/A | $0 | |
| Apr 23, 2019 | Pakianathan Deepika | Executive | Tender | 1,991,602 | $N/A | $0 | |
| Apr 23, 2019 | Pakianathan Deepika | Executive | Tender | 18,940 | $N/A | $0 | |
| Apr 23, 2019 | A. Lewicki John | Executive | Tender | 142,534 | $N/A | $0 | |
| Apr 23, 2019 | W. Lasersohn Jack | Executive | Tender | 185,709 | $N/A | $0 | |
| Apr 23, 2019 | W. Lasersohn Jack | Executive | Tender | 380,299 | $N/A | $0 | |
| Apr 23, 2019 | W. Lasersohn Jack | Executive | Tender | 1,119,905 | $N/A | $0 | |
| Apr 23, 2019 | D. Root Jonathan | Executive | Tender | 121,020 | $N/A | $0 | |
| Apr 23, 2019 | J. Hager Alicia | Executive | Tender | 39,488 | $N/A | $0 | |
| Dec 24, 2018 | Gurney Austin | Executive | Sale | 11,117 | $0.60 | $6.7K | |
| Oct 10, 2018 | A. Lewicki John | Executive | Sale | 1,156 | $2.01 | $2.3K | |
| Oct 10, 2018 | J. Hager Alicia | Executive | Sale | 1,156 | $2.02 | $2.3K | |
| Oct 10, 2018 | Gurney Austin | Executive | Sale | 1,156 | $2.01 | $2.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 44 | $23.3M | 60.1% |
Sale(S) | 176 | $14.9M | 38.4% |
Exercise(M) | 53 | $607.1K | 1.6% |
Tender(U) | 11 | $0 | 0.0% |
Gift(G) | 10 | $0 | 0.0% |
Award(A) | 25 | $0 | 0.0% |
Other(J) | 107 | $0 | 0.0% |
Conversion(C) | 98 | $0 | 0.0% |
Insiders at OncoMed Pharmaceuticals Inc are accumulating shares at an accelerated pace. With 27 insiders making 524 transactions totaling $23.3M in purchases versus $14.9M in sales, the net buying activity of $8.4M signals strong executive confidence. Deepika Pakianathan (Executive) leads the buying activity with $8.0M in transactions across all time.